Immune response to bacteria—distinguishing helpers from harmers

January 10, 2018, Universitaet Tübingen

Some staphylococcus bacteria live peacefully on human skin and membranes in a mutually beneficial relationship with their host, while others are able to exist far from a human host in soil or in water. When we come into contact with bacteria, the activation of our immune system is the first step to fighting off any imminent infection. Just how the immune system distinguishes between potential pathogens and harmless commensal bacteria is the focus of a study by a University of Tübingen team of microbiologists headed by Professor Friedrich Götz.

The researchers found the key in the long-chain fatty acids attached to the bacterial lipoproteins. The length of these determines the strength of our . The findings by Professor Götz and his team at the Interfaculty Institute of Microbiology and Infection Medicine are published in the latest Nature Communications.

The researchers investigated Staphylococcus aureus, a commensal bacterium on human skin. They compared it with Staphylococcus carnosus, which is often used as a starter culture for production of salami and other meat products. Using a particular receptor, the human immune system recognizes the lipoproteins on the ; these lipoproteins only occur in bacteria and are not produced by the human body. This enables our immune system to identify and respond to invaders from outside the body. "We found that the immune response to Staphylococcus aureus was much less intense than the response to Staphylococcus carnosus," Götz reports.

The researchers identified the differing structures of the bacterial lipoproteins as the main reason for this. In the case of S. aureus, the protein was modified by a long-chain heptadecanoyl fatty acid, while in S. carnosus the chain represented only a short acetyl group. "The difference in structure is comparatively small, yet it has an enormous influence on the immune response," Götz says. The long-chain lipoproteins on S. aureus led to a considerably reduced immune response, both in the innate and the adaptive immune system; while the short-chain lipoproteins on S. carnosus set off an immune response which was almost ten times stronger.

"This confirmed our theory that both pathogenic and can only survive in a host organism if they can escape or evade the immune system," says Götz. The bacteria have to either silence the immune system or work against it. "The mechanism whereby bacteria use long-chain lipoproteins to avoid an immune response, as the commensal S. aureus does, was previously unknown," Götz explains.

In contrast with the commensal , there are pathogenic microbes which may cause life-threatening diseases. "This leaves open the old question of why there is no real protective immune response to prevent infection by S. aureus," Götz says. His next step will be to investigate which enzymes and genes are involved in the fatty acid linkage in the S. aureus lipoproteins.

Explore further: Researcher exposes MRSA risk at northeast Ohio beaches

More information: Minh-Thu Nguyen et al. Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses, Nature Communications (2017). DOI: 10.1038/s41467-017-02234-4

Related Stories

Researcher exposes MRSA risk at northeast Ohio beaches

December 14, 2017
Beachgoers know there is always some risk of disease, but a recent study by a Kent State University researcher shows they may not be aware of all the dangers the beach poses.

Atopic dermatitis severity tied to IgG response to S. aureus

December 12, 2017
(HealthDay)—Atopic dermatitis (AD) disease severity is associated with immunoglobulin G (IgG) responses against Staphylococcus aureus antigens, according to a study published online Nov. 30 in the British Journal of Dermatology.

Scientists illuminate role of staph toxins in bacterial sepsis

February 2, 2017
Staphylococcus epidermidis bacteria are a significant health concern for hospitalized infants, children and anyone with implanted medical devices. The bacteria—typically skin dwellers—can infect the bloodstream and cause ...

Scientists decipher a mechanism in serious skin infections

January 24, 2017
Staphylococcus aureus is one of the most feared, multi-resistant pathogens. The bacterium often causes life-threatening infections, particularly in people with a weakened immune system. During the last few years, especially ...

Staphylococcus aureus bacteria turns immune system against itself

November 19, 2013
Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, including the antibiotic-resistant ...

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.